well so far all the court cases seem to last years for resolution. Take our Jublia Generic for example.......... ANDA filed 2017(?) orange book...... court case 2018ish, where we in 2022 still don't know the outcome....... even though the US FDA has given us approval for our Jublia Generic ( as well as some 10 others) but ACR cannot launch the product. So if Dapsone follows the same path it'll be 2030 before we are even told how it went.
- Forums
- ASX - By Stock
- ACR
- Ann: Acrux confirms patent challenge
Ann: Acrux confirms patent challenge, page-11
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.47M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.5¢ | $2.075K | 31.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 480468 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 41204 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 480468 | 0.065 |
1 | 71240 | 0.064 |
1 | 20918 | 0.063 |
1 | 60640 | 0.062 |
1 | 10000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 41204 | 3 |
0.070 | 107594 | 3 |
0.072 | 30000 | 1 |
0.075 | 15000 | 1 |
0.079 | 50000 | 1 |
Last trade - 14.15pm 02/08/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |